Menu
Sign In Pricing Add Podcast

BackTable Urology

Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

3267.233 - 3292.35 Jose Silva

And doctor, just a parenthesis regarding, you mentioned the short-acting testosterone and the possible side effects, going back to a baseline. So going back to where we talk about the prostate cancer, I mean, so will that also transcribe? I mean, can you have a patient, let's say, castrated levels with ADT, and can you give them pulses, just short pulses of testosterone at least to get a boost?

0
💬 0

Comments

There are no comments yet.

Log in to comment.